Top Markets
Coin of the day
TaiRx, Inc. TaiRx, Inc.

TaiRx, Inc.

6580
Rang în acțiuni #25843
TaiRx, Inc., established in 2011 and headquartered in Taipei City, Taiwan, is a... TaiRx, Inc., established in 2011 and headquartered in Taipei City, Taiwan, is a pharmaceutical company dedicated to the research, development, and commercialization of therapeutic solutions for cancer and other diseases. The company's clinical pipeline includes CVM-1118, an oral anti-cancer drug currently undergoing Phase II clinical trials, and Rexis, an add-on injection therapy for sepsis patients, which is in Phase III trials. In its pre-clinical stage, TaiRx is developing TRX-711 for secondary hyperparathyroidism, TRX-920 as an oral delivery formulation, and TRX-105, a molecule designed to treat and alleviate symptoms of various types of colitis. Beyond its developmental drugs, TaiRx also offers Zelnite, a medication that helps maintain patients' blood selenium levels and supports their immune systems. The company's future endeavors also involve the development of nodal diagnostic devices and innovative antibody-based drugs.
Preț acțiune
$0.40861751
Ultima sincronizare: 2026-08-20
Capitalizare de piață
$45.81M
Schimbare (1 zi)
-1.15%
Schimbare (1 an)
-45.04%
Țară
TW
Tranzacționează TaiRx, Inc. (6580)

Categorie

Istoric al prețului acțiunii pentru TaiRx, Inc. (6580)
Cel mai mare preț de închidere: $0.42 pe 2026-08-01

Cel mai mic preț de închidere: $1.41 pe 2017-06-01
Istoric al prețului acțiunii pentru TaiRx, Inc. din 2017 până în 2026
Evoluția anuală a prețului acțiunii
An Performanță
2026 (TTM) -13.14%
2025 -14.32%
2024 -0.12%
2023 -32.09%
2022 -18.00%
2021 52.04%
2020 57.15%
2019 -14.81%
2018 -18.47%
2017 0.00%
Prețul acțiunii pentru companii similare sau concurente
Companie Preț acțiune Variație 1an% Țara
$539.14 35.65%
US
$1.04K 56.21%
NL
$120.74 -16.83%
AU
$761.87 8.65%
CH
$130.43 397.46%
US